Development of NEO-811, a Molecular Glue Degrader of ARNT (HIF-1β) with Potent Single Agent Activity in ccRCC

By | 23 June 2026
  • Targeting an “undruggable” node
  • Discovery and mechanism
  • Preclinical efficacy and clinical progress